Comorbidities Resolution After MGB Surgery and Change in Body Composition

Sponsor
All India Institute of Medical Sciences, Bhubaneswar
Study ID
NCT06015620
Status
Recruiting
Apply to this trial

Conditions

  • Chronic Venous Hypertension With Ulcer
  • Hypertension
  • Hypothyroidism
  • Lipid Disorder
  • Morbid Obesity
  • Non-Alcoholic Fatty Liver Disease
  • Sleep Apnea
  • Type2diabetes

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

  • Mini gastric bypass surgery — PROCEDURE
    Mini gastric bypass surgery is a common metabolic or bariatric surgery done world wide for patients suffering from morbid obesity not managed by non surgical modalities of treatment.

Study Details

This observational study aims to learn about the correlation between the improving comorbidities associated with obesity after MGB (Mini-Gastric Bypass) surgery and changes in body composition in morbidly obese patients. The main questions it aims to answer are: To study the correlation between the improving comorbidities associated with obesity after MGB(Mini-Gastric Bypass) surgery and changes in body composition. Other objectives are: * Changes in the parameters of the metabolic syndrome after surgery * Changes in the cardiovascular risk biomarkers after metabolic surgery * Emergence in complications arising out of surgery requiring any intervention or causing a prolonged hospital stay, or requiring additional outpatient visits. Type of Study: An observational study in which participants with morbid obesity will undergo mini-gastric bypass surgery as per routine protocol. No separate experimental interventions will be done in the study for the participants.

Key Dates

First listed
Aug 29, 2023
Start date
Sep 1, 2023
Status verified
Feb 2026
Primary completion
Dec 31, 2026
Completion
Mar 30, 2027

Study Design

Enrollment
35 participants (estimated)

Arms

  • Arm: Patients with morbid obesity undergoing metabolic surgery (Mini gastric bypass)
    The patients undergoing mini gastric bypass surgery for morbid obesity and its different comorbidities like type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, hypothyroidism and chronic venous hypertension.

Primary Outcome Measure

To study the correlation between the improving comorbidities associated with obesity after MGB(Mini-Gastric Bypass) surgery and changes in body composition. [ Time Frame: 3 years ]

Central Contacts

Find similar trials

Nationwide
Hypertension (high blood pressure) trialsCardiology trialsHeart disease trials

Related Studies